“The Valuation was Flawed, the Correct Alternatives were Not Properly Considered”

The question marks around the Transaction: Prof. Haim Kedar-Levi claims that the high-value estimate given by the Merrill Lynch investment bank to Yes prior to its sale to Bezeq did not account for important variables, such as the possibility that the synergy between the two companies would not be realized. Kedar-Levi composed a complementary opinion supporting a derivative claim filed by Ronen Adini & Co against Bezeq and its directors, for the Transaction, which is taking place in the Tel Aviv District Court (The Economic Division).